Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in ER (+) and/or PR (+) and HER2 (−) Breast Cancer

Background: Although intrinsic molecular subtype has been widely used, there remains great clinical heterogeneity of prognosis in the estrogen receptor (ER)- and/or progesterone receptor (PR)-positive and human epidermal growth factor receptor 2 (HER2)-negative breast cancer (BC). Methods: The trans...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Feng, Zheng, Fangchao, Han, Ying, Zhao, Jiuda, Yuan, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9201983/
https://www.ncbi.nlm.nih.gov/pubmed/35721151
http://dx.doi.org/10.3389/fphar.2022.820437

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9201983/
https://www.ncbi.nlm.nih.gov/pubmed/35721151
http://dx.doi.org/10.3389/fphar.2022.820437

Ejemplares similares